Home / Research library / Pal-GHK
Pal-GHK: molecular data, studies & sources
Pal-GHK is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C30H54N6O5
- Molecular weight (MW)
- 578.8 g/mol
- PubChem compound ID
- 10231864
- Record title
- Palmitoyl Tripeptide-1
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 10231864 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-6-amino-2-[[(2S)-2-[[2-(hexadecanoylamino)acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid
- InChIKey
- BYUQATUKPXLFLZ-UIOOFZCWSA-N
- SMILES
- CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCCN)C(=O)O
Identifiers & sequence
- PubChem CID
- 10231864
- CAS Registry Number
- 147732-56-7via ChemIDplus, EPA DSSTox, FDA GSRS
- FDA UNII
- RV743D216M
- InChIKey
- BYUQATUKPXLFLZ-UIOOFZCWSA-N
- Wikidata
- Q27288301
Peptide sequence · 3 residues (one-letter code; X marks a residue without a one-letter code)
GHK
Condensed notation with terminal groups and non-standard residues
palmitoyl-Gly-His-Lys-OH
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 578.4156 Da |
|---|---|
| Heavy atoms | 41 |
| Hydrogen-bond donors | 6 |
| Hydrogen-bond acceptors | 6 |
| Rotatable bonds | 26 |
| Topological polar surface area | 179.3 Ų |
| Calculated logP (Crippen) | 3.73 |
| Rings | 1 |
| Stereocenters | 2 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Palmitoyl tripeptide-1 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received Palmitoyl tripeptide-1, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.
Pal-GHK supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Pal-GHK for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Cenexa LabsUSD | 200mg Powder1 recorded offers | 200mg Powder · $205.99Checked Nov 6, 2026Supplier listing, Pal-GHK 200mg Powder, Cenexa Labs, opens in a new tab |
Reference sources & further reading
- PubChem compound record 10231864 — chemical identity and structure.
- FDA Global Substance Registration System: UNII RV743D216M — substance identity, names and codes.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Acetyl Hexapeptide-3 (Argireline)
C35H62N14O11S
887.0 g/mol · PubChem CID 71587772
6 selected publications · 1 human intervention study · 3 registered trials
AHK-Cu
Molecular identity needs further verification
1 selected publication · 0 human intervention studies
Decapeptide-12
Molecular identity needs further verification
3 selected publications · 2 human intervention studies
GHK Basic (Tripeptide-1)
Molecular identity needs further verification
5 selected publications · 0 human intervention studies
Kisspeptin-10
C63H83N17O14
1302.4 g/mol · PubChem CID 25240297
5 selected publications · 3 human intervention studies · 5 registered trials
Protein / peptide · highest stage: Phase 3
Lipopeptide (Biopeptide EL)
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies